Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia

Objective: To explore the treatment response, tolerability and safety of once-monthly paliperidone palmitate (PP1M) in non-acute patients switched from oral antipsychotics, stratified by time since diagnosis as recently diagnosed (≤3 years) or chronic patients (>3 years). Research design and meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Hargarter, L, Bergmans, P, Cherubin, P, Keim, S, Conca, A, Serrano-Blanco, A, Bitter, I, Bilanakis, N, Schreiner, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898156/
https://www.ncbi.nlm.nih.gov/pubmed/27042990
http://dx.doi.org/10.1080/14656566.2016.1174692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898156/
https://www.ncbi.nlm.nih.gov/pubmed/27042990
http://dx.doi.org/10.1080/14656566.2016.1174692

Ejemplares similares